Hodgkins Disease Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
W
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
- Atlanta, Georgia
- +2 more
2022-02-09
Feb 9, 2022B
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Antithymocyte Globulin
- Clofarabine
- Boston, Massachusetts
- +1 more
2022-01-25
Jan 25, 2022C
Active, not recruiting
- Chronic Myelogenous Leukemia
- +9 more
- tacrolimus
- +3 more
- Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
2021-08-04
Aug 4, 2021C
Completed
- Non-Hodgkin's Lymphoma
- Hodgkins Disease
- Fludarabine
- +2 more
- Chicago, Illinois
- +5 more
2019-03-04
Mar 4, 2019U
Completed
- Acute Myelogenous Leukemia
- +8 more
- Pentostatin
- +4 more
- Omaha, NebraskaUniversity of Nebraska Medical Center, Section of Oncology/Hemat
2018-11-16
Nov 16, 2018A
Completed
- Brain Tumors
- +5 more
- Aromatherapy Scented Wand
- Placebo wand
- Bronx, New YorkChildren's Hospital at Montefiore
2018-09-06
Sep 6, 2018S
Completed
- Tumors
- +2 more
- San Antonio, Texas
- +2 more
2015-09-18
Sep 18, 2015I
Terminated
- Hodgkins Disease
- Proton
- Bloomington, IndianaIndiana University Health Proton Therapy Center
2015-02-03
Feb 3, 2015D
Completed
- Multiple Myeloma
- +2 more
- G-CSF plus Plerixafor
- Durham, North CarolinaDuke University Medical Center
2014-04-08
Apr 8, 2014T
Terminated
- Acute Myelogenous Leukemia
- +8 more
- Busulfan
- +6 more
- Amarillo, TexasTexas Oncology
2013-11-21
Nov 21, 2013F
Completed
- Leukemia
- +3 more
- Seattle, WashingtonFred Hutchinson Cancer Research Center
2012-02-13
Feb 13, 2012W
Completed
- Lymphoma, Non-Hodgkins
- Hodgkins Disease
- New York, New YorkWeill Cornell Medical College
2009-03-10
Mar 10, 2009